[Application of methods of renal replacement therapy for abolishment of hyperhydration in patients with decompensated chronic heart failure].
Slow continuous ultrafiltration (SCUF), continuous veno venous haemofiltration (CVVHF) are alternative to diuretics methods of treatment of patients with chronic heart failure (CHF), edematous syndrome.


METHODS
Patients of both sexes aged 30-82 years with functional class II-IV CHF were included because of decompensation of CHF. Randomization: experiment - 19 patients, 3-4 component therapy plus SCUF or CVVHF; control - 3-4 component therapy plus intravenous furosemide.


RESULTS
I ñ at baseline, II ñ after compensation of CHF.


RESULTS
Delta weight (kg) - experiment -10.1+/-1.08, control -1.92+/-0.83, p=0.00001; Delta left ventricular ejection fraction - experiment +10.09+/-2.26, control +0.52+/-1.14, p=0.0007; pulmonary artery systolic pressure (mm Hg) - experiment -12.32+/-3,43, control -4.05 +/-2.07, p=0.029; Delta 6 min walk test: experiment +304.22+/-39.4, control +91.91+/-23.4, p=0.00003; Delta glomerular filtration rate - experiment -1.16+/-3.23, control +4.44+/-3.68, p=0.85; duration of hospitalization (days) - experiment 17.26+/-1.43, control 17.52+/-1.02, p=0.59. We did not observe complications related to renal replacement therapy.


CONCLUSIONS
SCUF and CVVHF are safe for patients. In decompensated CHF SCUF and CVVHF provide greater weight reduction and fluid removal than intravenous diuretics, abolish hypervolemia what cause improvement of myocardial contractility.
E A
EA
Tabak'ian
A Iu
AIu
Zaruba
R P
RP
Miasnikov
D M
DM
Ataullakhanova
V V
VV
Kukharchuk
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use; D004489:Edema, Cardiac / Q000188:drug therapy / Q000628:therapy; D005260:Female; D005665:Furosemide / Q000008:administration & dosage / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy / Q000628:therapy*; D006440:Hemofiltration; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D017582:Renal Replacement Therapy / Q000379:methods*; D013997:Time Factors; D016896:Treatment Outcome; D014462:Ultrafiltration; D016138:Walking; D015431:Weight Loss
D004232:Diuretics; D005665:Furosemide